Finasteride & Dutasteride Hub

Finasteride and dutasteride are prescription “DHT blockers” (5-alpha reductase inhibitors). They’re mainly used in male pattern hair loss when diagnosis is clear and long-term treatment is acceptable. This hub organizes your key guides and highlights the safety points that matter most (mood, sexual side effects, PSA testing, and pregnancy handling warnings).

Medical note: This page is for general education and does not provide personal medical advice. These are prescription medicines and are not appropriate for everyone. If you’re not sure you have pattern hair loss, start here: How Hair Loss Is Diagnosed. If you have red flags (pain/burning, pus, heavy scale, rapid loss), read: When to See a Doctor.


Quick navigation


Start here (fast)

For readers still deciding whether a DHT-blocker belongs in the first treatment step at all, the cleanest decision page is Which Hair Loss Treatment Should I Start First?.

If the practical issue is not “start or not” but whether miniaturized hairs may still improve in caliber with treatment, move next to Can Miniaturized Hair Grow Back Thicker?.

When the real concern is weak response, premature judgment, or the possibility that the diagnosis itself still needs rechecking, use Hair Loss Treatment Not Working? Next Steps.

To interpret slower loss, improved stability, or gradual visible improvement more realistically, use Signs Hair Loss Treatment Is Working.

If timing is the sticking point, and the question is how long finasteride or dutasteride should reasonably get before you judge the plan, use How Long Hair Loss Treatment Takes to Work.

For mood changes, sexual side effects, or other treatment-related symptoms that may change the decision, the most useful safety page is Hair Loss Treatment Side Effects: When to Recheck.

If the reader is thinking about stopping treatment and wants to know what usually happens after discontinuation, send them to Stopping Hair Loss Treatment: What Happens Next.

When the question becomes whether the current DHT-blocker plan needs more time, a different strategy, or a change because of tolerability or weak response, the best bridge page is When to Switch Hair Loss Treatment.

Core guides on this site

If you are trying to decide whether thinning is shedding-related or pattern-based, start with:

Finasteride vs dutasteride (key differences)

  • Finasteride (1 mg): FDA-approved for male pattern hair loss in men (product labeling varies by country). It inhibits type II 5α-reductase and lowers DHT signaling. Use is typically long-term.
  • Dutasteride (0.5 mg): FDA-approved for BPH, not approved for hair loss in the U.S. (hair-loss use is “off-label” in some settings). It inhibits type 1 and type 2 5α-reductase, and has a long persistence in the body.

Practical interpretation: when clinicians discuss dutasteride for hair loss, it is usually in the context of insufficient response to finasteride or more aggressive progression, and always with a clinician-led risk discussion.

Timeline: when to judge results

  • Labeling for finasteride notes that 3 months or more of daily use may be needed before benefit is observed.
  • Patient leaflets commonly emphasize that meaningful change can take many months, and that stopping typically leads to gradual loss of gains.

Safety: mood, sexual side effects, PSA

  • Mood: European regulators (EMA) confirmed suicidal ideation as a side effect of finasteride tablets and recommended risk-minimisation measures (including patient information materials). UK MHRA also reminds clinicians/patients about psychiatric side effects.
  • Sexual side effects: Dermatology leaflets describe recognised sexual side effects in a minority of users; MHRA notes sexual dysfunction reports (including persistence after discontinuation in some cases).
  • PSA testing: 5-alpha reductase inhibitors can lower PSA. Tell your clinician before PSA testing so interpretation is appropriate.

Pregnancy / handling warnings

  • Finasteride: women who are pregnant or may become pregnant should not handle crushed/broken tablets due to absorption risk and potential harm to a male fetus.
  • Dutasteride: women who are pregnant or may become pregnant should not handle leaking capsules; dutasteride can be absorbed through the skin.
  • Dutasteride blood donation: labeling advises men not to donate blood for a period after stopping, to prevent exposure to pregnant recipients.

Monitoring checklist (practical)

  • Diagnosis first: confirm pattern loss (AGA) before committing to long-term therapy.
  • Baseline photos: same lighting/angle monthly (hair changes are slow).
  • Mood check: if depressed mood or suicidal thoughts occur, stop and seek medical advice promptly.
  • PSA note: tell your clinician before PSA tests.
  • Pregnancy safety: store securely; avoid exposure of broken tablets/leaking capsules to pregnant women.

References (trusted medical sources)

Last updated: April 24, 2026.

Contact Form